Orexigen

Orexigen’s Weight-Loss Roller Coaster to End With a Bankruptcy Sale
Xconomy
Mon, 03/12/18 - 09:47 am
Orexigen
bankruptcy
Contrave
Orexigen posts a ‘for sale’ sign in the yard as weak Contrave sales raise concerns
Endpoints
Tue, 10/17/17 - 09:50 am
Orexigen
Contrave
M&A
Orexigen - Contrave Sales Present Troubling Data
Seeking Alpha
Tue, 06/21/16 - 11:21 am
Orexigen
Contrave
obesity
Orexigen struggles to stay afloat as obesity market stagnates
BioPharma Dive
Thu, 05/19/16 - 09:43 am
Orexigen
obesity
Contrave
Vivus
Qsymia
Takeda
Arena Investors: What To Consider As Anti-Obesity Drugs Fizzle
Seeking Alpha
Mon, 05/16/16 - 09:32 pm
Arena Pharmaceuticals
obesity
Orexigen
Belviq
Eisai
Vivus
Novo Nordisk
Qsymia
Victoza
Orexigen Therapeutics posts 1st-quarter loss of $22.3 million
Yahoo/AP
Wed, 05/4/16 - 06:46 pm
Orexigen
earnings
Orexigen Pulls The Plug On Post-Marketing Cardiovascular Trial
Seeking Alpha
Sat, 04/16/16 - 04:27 pm
Orexigen
Contrave
Orexigen: Contrave Sales Flatten Out At End Of Q1
Seeking Alpha
Mon, 04/11/16 - 09:58 am
Orexigen
Contrave
obesity
Novo Nordisk
Vivus
Arena Pharmaceuticals
Orexigen buys U.S. obesity pill rights from Takeda, partners Valeant
Yahoo/Reuters
Tue, 03/15/16 - 09:32 am
Orexigen
obesity
Contrave
Takeda
Valeant Pharmaceuticals
M&A
Orexigen takes another body blow from ill-fated Contrave trial
Fierce Pharma
Wed, 03/9/16 - 03:40 pm
Orexigen
Contrave
obesity
Takeda
clinical trials
The Next 6 Months Are Critical For Orexigen
Seeking Alpha
Wed, 03/2/16 - 10:51 am
Orexigen
Hoping Vivus and Orexigen can finally kick-start their obesity meds? Don't count on it, analyst says
Fierce Pharma Marketing
Tue, 03/1/16 - 10:56 pm
obesity
Vivus
Orexigen
Contrave
Qsymia
Takeda
Belviq Sales Close Out 2015 With A Slump
Seeking Alpha
Sat, 01/9/16 - 10:39 am
Belviq
Arena Pharmaceuticals
obesity
Vivus
Orexigen
Are Takeda's 900 Contrave reps worth it? Maybe not, analyst says
Fierce Pharma Marketing
Mon, 11/9/15 - 03:38 pm
Takeda
Contrave
drug reps
Orexigen
10 Worst NASDAQ Biotech Stocks in the Third Quarter
TheStreet.com
Wed, 09/30/15 - 07:51 pm
Orexigen
Immunomedics
Celldex Therapeutics
Arena Pharmaceuticals
Theravance
Karyopharm
Raptor Pharmaceutical
Verastem
Tetraphase
Xoma
Contrave script growth snags, despite Takeda's 900-strong salesforce
Fierce Pharma Marketing
Tue, 09/29/15 - 09:16 am
Contrave
Takeda
Orexigen
obesity
Why Hasn't Orexigen Launched Its Obesity Drug in Europe Yet?
Motley Fool
Sat, 09/19/15 - 09:14 am
Orexigen
Europe
drug launches
obesity
Mysimba
Contrave
Orexigen Therapeutics reports second-quarter loss, misses expectations
Yahoo/AP
Thu, 08/6/15 - 10:20 am
Orexigen
earnings
Orexigen - Contrave Takes Sales Lead In The U.S. - More Sales Still Needed
Seeking Alpha
Mon, 06/22/15 - 12:49 pm
Orexigen
Contrave
obesity
Arena Pharmaceuticals
Vivus
Brutal honesty in drug marketing? For obesity meds, it's key to avoiding the 'magic pill' trap
Fierce Pharma Marketing
Mon, 06/8/15 - 12:13 pm
obesity
Takeda
Contrave
Orexigen
Vivus
Qsymia
Eisai
Belviq
Arena Pharmaceuticals

Pages